2 years ago
BKNG
AnalystsEdward WooEdward Woo's Stock Forecasts
AnalystsEdward Woo
Analyst Ranking
Bottom 2%
#5134 out of 5186 analysts
Average Return
-7.4%
Win Rate
32%77 out of 238
Risk vs Reward
Poor
Good
Edward Woo's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aim Immunotech IncAIM | +595.40% | $0.35 | $2.42 | 2024-09-02 - 2025-09-02 | Buy |
Quantum Computing IncQUBT | +593.18% | $0.88 | $6.10 | 2023-11-23 - 2024-11-22 | Buy |
Aim Immunotech IncAIM | +583.49% | $0.22 | $1.49 | 2024-12-09 - 2025-12-09 | Buy |
Streamex CorpSTEX | +514.23% | $0.53 | $3.28 | 2025-04-20 - 2026-02-06 | Buy |
Quantum Computing IncQUBT | +318.80% | $2.66 | $11.14 | 2024-11-12 - 2025-11-12 | Buy |
Edward Woo Analyst Color
Get additional color on Edward Woo's coverage of popular stocks
Edward Woo's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Synergy Chc CorpSNYR | 1 | Buy | $5.00 | +182.49% | Initiates Coverage On | 5 days ago |
Nrx Pharmaceuticals IncNRXP | 7 | Buy | $48.00 | +2,413.09% | Maintains | a month ago |
Maison Solutions IncMSS | 3 | Buy | $4.50 | +1,678.66% | Maintains | a month ago |
Duos Technologies Group IncDUOT | 8 | Buy | $14.00 | +46.44% | Maintains | a month ago |
Alzamend Neuro IncALZN | 7 | Buy | $28.00 | +1,314.14% | Maintains | 2 months ago |
Quantum Computing IncQUBT | 6 | Buy | $25.00 | +165.11% | Maintains | 2 months ago |
Surgepays IncSURG | 9 | Buy | $9.75 | +883.85% | Maintains | 2 months ago |
Genasys IncGNSS | 5 | Buy | $5.25 | +166.50% | Maintains | 2 months ago |
Outlook Therapeutics IncOTLK | 6 | Buy | $10.00 | +2,231.00% | Maintains | 2 months ago |
Society Pass IncorporatedSOPA | 7 | Buy | $22.50 | +1,342.31% | Maintains | 2 months ago |
Knightscope IncKSCP | 5 | Buy | $25.00 | +598.32% | Maintains | 2 months ago |
Banzai International IncBNZI | 7 | Buy | $23.00 | +1,832.77% | Maintains | 2 months ago |
Aytu Biopharma IncAYTU | 3 | Buy | $13.00 | +443.93% | Maintains | 2 months ago |
Lucid Diagnostics IncLUCD | 8 | Buy | $8.25 | +576.23% | Maintains | 2 months ago |
Pavmed IncPAVM | 8 | Buy | $510.00 | +4,622.22% | Maintains | 2 months ago |
Igc Pharma IncIGC | 7 | Buy | $4.75 | +1,800.00% | Maintains | 2 months ago |
Allarity Therapeutics IncALLR | 3 | Buy | $9.50 | +1,043.20% | Maintains | 2 months ago |
Atossa Therapeutics IncATOS | 7 | Buy | $40.00 | +649.06% | Maintains | 2 months ago |
Aim Immunotech IncAIM | 4 | Buy | $22.00 | +1,829.82% | Maintains | 2 months ago |
Sintx Technologies IncSINT | 4 | Buy | $16.00 | +444.22% | Maintains | 2 months ago |
Gri Bio IncGRI | 5 | Buy | $1,008.00 | +42,075.73% | Maintains | 2 months ago |
Intrusion IncINTZ | 6 | Buy | $12.50 | +1,258.70% | Maintains | 2 months ago |
Cingulate IncCING | 4 | Buy | $58.00 | +653.25% | Maintains | 2 months ago |
Endra Life Sciences IncNDRA | 5 | Buy | $30.00 | +671.21% | Maintains | 2 months ago |
Plus Therapeutics IncPSTV | 6 | Buy | $19.00 | +7,207.69% | Maintains | 3 months ago |
Myomo IncMYO | 6 | Buy | $10.00 | +1,145.33% | Maintains | 3 months ago |
Renovorx IncRNXT | 7 | Buy | $12.50 | +1,162.63% | Maintains | 3 months ago |
Aemetis IncAMTX | 5 | Buy | $20.00 | +1,157.86% | Maintains | 3 months ago |
TravelzooTZOO | 6 | Buy | $23.00 | +309.25% | Maintains | 3 months ago |
Phunware IncPHUN | 6 | Buy | $12.50 | +598.32% | Maintains | 8 months ago |
Streamex CorpSTEX | 4 | Buy | $10.00 | +204.88% | Maintains | 8 months ago |
Ton Strategy CoTONX | 4 | Buy | $62.00 | +3,063.27% | Maintains | 8 months ago |
Envoy Medical IncCOCH | 5 | Buy | $9.50 | +1,912.71% | Maintains | 8 months ago |
Pro Dex IncPDEX | 4 | Buy | $56.00 | +41.95% | Maintains | 8 months ago |
Groupon IncGRPN | 8 | Buy | $19.00 | +42.96% | Maintains | a year ago |
Daxor CorpDXR | 3 | Buy | $25.00 | +102.51% | Maintains | a year ago |
Electronic Arts IncEA | 2 | Buy | $160.00 | -20.00% | Maintains | a year ago |
Take Two Interactive Software IncTTWO | 11 | Buy | $270.00 | +38.04% | Maintains | a year ago |
Datavault Ai IncDVLT | 3 | Buy | $11.00 | N/A | Maintains | a year ago |
Biolase IncBIOL | 2 | Buy | $2.00 | N/A | Maintains | a year ago |
Mira Pharmaceuticals IncMIRA | 1 | Buy | $11.00 | N/A | Initiates Coverage On | 2 years ago |
Jakks Pacific IncJAKK | 1 | Buy | $38.00 | N/A | Maintains | 2 years ago |
Booking Holdings IncBKNG | 2 | Buy | $3,900.00 | N/A | Maintains | 2 years ago |
Expedia Group IncEXPE | 1 | Buy | $168.00 | N/A | Maintains | 2 years ago |
Tripadvisor IncTRIP | 1 | Buy | $30.00 | N/A | Maintains | 2 years ago |
Algorhythm Holdings IncRIME | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Heartsciences IncHSCS | 1 | Buy | $330.00 | N/A | Initiates Coverage On | 3 years ago |
Vivos Therapeutics IncVVOS | 1 | Buy | $62.50 | N/A | Initiates Coverage On | 3 years ago |
Autoweb IncAUTO | 1 | Hold | $0.39 | N/A | Downgrades | 3 years ago |
Guardion Health Sciences IncGHSI | 1 | Buy | $37.50 | N/A | Initiates Coverage On | 4 years ago |
Blackboxstocks IncBLBX | 1 | Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Novabay Pharmaceuticals IncNBY | 3 | Buy | $4,900.00 | N/A | Maintains | 4 years ago |
Activision Blizzard IncATVI | 3 | Buy | $95.00 | N/A | Maintains | 4 years ago |
Gamestop CorpGME | 8 | Sell | $5.75 | N/A | Maintains | 4 years ago |
Blue Nile IncNILE1 | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 4 years ago |
Imac Holdings IncBACK | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.